Immunovant Sciences Gmbh

This study follows up on a previous trial to check the long-term safety of batoclimab, an investigational treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). About 108 adults who completed the earlier study will receive weekly injections for up to one year. Th…

This study is testing whether an experimental drug called IMVT-1402 can help control rheumatoid arthritis in adults whose disease hasn't responded well to other treatments. About 120 participants will receive the drug or a placebo to see if it reduces joint swelling and pain. The…

This study continues research on batoclimab for thyroid eye disease in people who finished earlier trials. It has two parts: one observes how long eye improvements last without treatment, while the other gives batoclimab to measure its effectiveness. The study involves 180 partic…

This study is testing whether weekly injections of an experimental drug called batoclimab can reduce eye bulging and inflammation in people with active Thyroid Eye Disease. About 100 participants will receive either the drug or a placebo for 24 weeks to see which is better at pul…

This study follows adults with Graves' disease who have already tried the drug IMVT-1402 in earlier trials. The main goal is to see if the drug can help patients maintain normal thyroid function long-term without needing standard anti-thyroid drugs or even the study drug itself. …

This study is testing whether weekly injections of an experimental drug called batoclimab can help adults with generalized myasthenia gravis (gMG), a chronic autoimmune disease that causes severe muscle weakness. Researchers are comparing two different doses of the drug against a…